In an in vivo study using NOD/SCID mice injected with A549 CD133+ cells, curcumin, RSL3, or iFSP1 treatments suppressed tumor growth, enhanced tumor pathology, and lowered Ki-67 expression. Here, PROM1 is linked to neoplasm.